|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4196 | |
| A61K 31/506 | |||
| A61P 31/00 |
| (11) | Patento numeris | 1713477 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05702261.8 |
| Europos patento paraiškos padavimo data | 2005-01-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2006-10-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2008-10-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2005/000098 |
| Data | 2005-01-13 |
| (87) | Numeris | WO 2005/084671 |
| Data | 2005-09-15 |
| (30) | Numeris | Data | Šalis |
| 0402491 | 2004-02-04 | GB | |
| 545663 P | 2004-02-17 | US |
| (72) |
HUMPHREY, Michael John, GB
|
| (73) |
Pfizer Limited,
Ramsgate Road, Sandwich, Kent CT13 9NJ,
GB
Pfizer Inc., 235 East 42nd Street, New York NY 10017, US |
| (54) | COMBINATION OF VORICONAZOLE AND AN ANTIFUNGAL CYP2C19 INHIBITOR |
| COMBINATION OF VORICONAZOLE AND AN ANTIFUNGAL CYP2C19 INHIBITOR |